PHARMACOLOGICAL AND NONPHARMACOLOGICAL INTERVENTIONS IN THE TREATMENT OF PARKINSONS-DISEASE

被引：45
作者：
CUTSON, TM
LAUB, KC
SCHENKMAN, M
机构：
[1] DUKE UNIV, MED CTR, CLAUDE D PEPPER OLDER AMER INDEPENDENCE CTR, DEPT MED, DURHAM, NC 27710 USA
[2] VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, DURHAM, NC 27705 USA
[3] DUKE UNIV, MED CTR, CLAUDE D PEPPER OLDER AMER INDEPENDENCE CTR, DEPT PHYS THERAPY, DURHAM, NC 27710 USA
[4] DUKE UNIV, MED CTR, CLAUDE D PEPPER OLDER AMER INDEPENDENCE CTR, GRAD PROGRAM PHYS THERAPY, DURHAM, NC 27710 USA
来源：
PHYSICAL THERAPY | 1995年 / 75卷 / 05期
关键词：
NEUROMUSCULAR DISORDERS; PARKINSONS DISEASE; PHARMACOLOGY; PHYSICAL THERAPY;
D O I：
10.1093/ptj/75.5.363
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
Parkinson's disease is a neurodegenerative disorder of older persons that eventually leads to disability. It is characterized by tremor, rigidity, bradykinesia, and postural instability. Progressive stages can be identified, each with unique problems. The optimal management of Parkinson's disease requires multiple professionals to address the needs of the patient as well as those of the caregivers. In addition to pharmacologic management, patients with Parkinson's disease cart benefit from physical intervention and psychological support. This article summarizes strategies incorporating the multiple disciplines for each stage of the disease.
引用
收藏
页码：363 / 373
页数：11
相关论文
共 70 条
[11]  
COTE L, 1991, PRINCIPLES NEURAL SC, P647
[12]   AROMATIC AMINO ACIDS AND MODIFICATION OF PARKINSONISM [J].
COTZIAS, GC ;
VANWOERT, MH ;
SCHIFFER, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) :374-&
[13]  
COUGHLIN L, 1980, CLIN ORTHOP RELAT R, P192
[14]  
Cummings JL, 1992, PARKINSONS DIS NEURO, P313
[15]   PRIMATE MODELS OF MOVEMENT-DISORDERS OF BASAL GANGLIA ORIGIN [J].
DELONG, MR .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :281-285
[16]  
Fahn S. M. C., 1987, RECENT DEV PARKINSON, P153
[17]  
FRANKLYN S, 1981, BRIT MED J, V282, P1969
[18]  
GANCHER ST, 1992, PARKINSONS DISEASE N, P273
[19]  
GARRETT HM, 1994, RED BOOK PHARMACYS F
[20]  
GOETZ CG, 1993, NEUROLOGY, V43, P1
1234567